Differential effect of aspirin on platelet aggregation in patients with coronary artery disease: In relation with assciated risk factors

Japanese Heart Journal

Volumn 44, Issue 1, 2003, Pages 21-29

  Ersöz, Gülriz ^a   Tikiz, Hakan ^b   Yakaryilmaz, Ali ^b   Tezcan, Kemal ^b   Genç, Yasemin ^a   Korkmaz, Şule ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Aspirin; Coronary artery disease; Platelet aggregation

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; COLLAGEN; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION; DIABETIC ANGIOPATHY; HYPERLIPIDEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ADULT; AGED; ASPIRIN; CORONARY DISEASE; DIABETIC ANGIOPATHIES; DOUBLE-BLIND METHOD; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SMOKING;

EID: 0037270261     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.44.21     Document Type: Article

References (18)

1. Stormorken H, Sakariassen KS. Homeostatic risk factors in arterial thrombosis and atherosclerosis: the thrombin-fibrin and platelet-VWF axis. Thromb Res 1997; 88: 1-25.
2. Patrono C, Renda G. Platelet activation and inhibition in unstable coronary syndromes. Am J Cardiol 1997; 80: 17E-20E.
3. Fuster V. Mechanisms leading to myocardial infarcton: insights from studies of vascular biology. Circulation 1994; 90: 2126-46.
4. Schafer AI. Antiplatelet therapy. Am J Med 1996; 101: 199-209.
5. Awtry EH, Loscalzo J. Aspirin. Circulation 2000; 101: 1206-18.
6. Gear ARL. Platelet adhesion, shape change and aggregation: rapid initiation and signal transduction events. Can J Physiol 1994; 72: 185-294.
7. Folts JD. Inhibition of platelet activity in vivo by amlopidine alone and combined with aspirin. Int J Cardiol 1997; 62: S111-7.
8. Theroux P. Antiplatelet therapy: Do the new platelet inhibitors add significantly to the clinical benefits of aspirin. Am Heart J 1997; 134: S62-70.
9. Maalej N, Folts JD. Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries. Circ 1996; 93: 1201-5.
10. Ingerman-Wojenski CM, Smith JB, Silver MJ. Evaluation of electrical aggregometry: comparison with optical aggregometry, secretion of ATP and accumulation of radiolabeled platelets. J Lab Clin Med 1983; 101, 44-52.
11. Harrington RA, Kleiman NS, Granger CB, Ohman EM, Berkowitz SD. Relation between inhibition of platelet aggregation and clinical outcomes. Am Heart J 1998; 136: S43-50.
12. Schechter M, Merz NB, Paul-Labrador MJ, Kaul S. Blood glucose and platelet-dependent thrombosis with coronary artery disease. J Am Coll Cardiol 2000; 35: 301-7.
13. Hung J, Lam JYT, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circ 1995; 92, 2432-6.
14. Schrör K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Sem Thromb Hemostat 1997; 23: 349-56.
15. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemostasis 1993; 70: 119-23.
16. Moake J, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets as well as by exogenous large or unusually large vWF multimers, requires adenosine diphoshate, and is resistant to aspirin. Blood 1988; 71: 1366-74.
17. Larsson PT, Wallen NH, Hjemdal P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circ 1994; 89: 1951-7.
18. Quyyumi A. Effects of aspirin on endothelial dysfunction in atherosclerosis. Am J Cardiol 1998; 82: 31S-3S.